Abstract
Recent studies describe beneficial effects of bone marrow-derived mesenchymal stem cell infusion in animal models as well as in patients. However, data on the homing abilities of primary and culture-expanded MSC are lacking. In order to systematically investigate MSC homing we compared the fate of both primary and cultured MSC in a syngeneic mouse model. Twenty-four hours after transplantation of uncultured EGFP-transgenic MSC into sublethally irradiated mice, as many as 55–65% of injected CFU-F were recovered from the BM and 3.5–7% from the spleen. In the subsequent 4 weeks these donor CFU-F expanded 100-fold, which resulted in a normalization of femoral and splenic CFU-F numbers. This highly efficient homing of primary CFU-F contrasted with the defective homing of MSC following culture. Following their infusion immortalized multipotent syngeneic stromal cells were undetectable in BM, spleen, lymph nodes or thymus. Remarkably, following transplantation of primary MSC that had been cultured for only 24 h the seeding fraction in the BM was reduced to 10%, while after transplantation of 48 h cultured primary MSC no CFU-F were detected in the lymphohematopoietic organs. These data suggest that in vitro propagation of BM-derived MSC dramatically decreases their homing to BM and spleen.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Almeida-Porada, G, Porada, CD, Tran, N & Zanjani, ED Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood, (2000). 95, 3620–3627.
Beresford, JN, Bennett, JH, Devlin, C, Leboy, PS & Owen, ME Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci, (1992). 102, 341–351.
Cheng, L, Qasba, P, Vanguri, P & Thiede, MA Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. J Cell Physiol, (2000). 184, 58–69.
Dennis, JE, Merriam, A, Awadallah, A, Yoo, JU, Johnstone, B & Caplan, AI A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res, (1999). 14, 700–709.
Haynesworth, SE, Goshima, J, Goldberg, VM & Caplan, AI Characterization of cells with osteogenic potential from human marrow. Bone, (1992). 13, 81–88.
Johnstone, B, Hering, TM, Caplan, AI, Goldberg, VM & Yoo, JU In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, (1998). 238, 265–272.
Young, RG, Butler, DL, Weber, W, Caplan, AI, Gordon, SL & Fink, DJ Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res, (1998). 16, 406–413.
Caplan, AI Mesenchymal stem cells. J Orthop Res, (1991). 9, 641–650.
Prockop, DJ Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, (1997). 276, 71–74.
Friedenstein, AJ, Deriglasova, UF, Kulagina, NN, Panasuk, AF, Rudakowa, SF, Luria, EA & Ruadkow, IA Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol, (1974). 2, 83–92.
Liechty, KW, MacKenzie, TC, Shaaban, AF, Radu, A, Moseley, AM, Deans, R, Marshak, DR & Flake, AW Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med, (2000). 6, 1282–1286.
Pereira, RF, Halford, KW, O’Hara, MD, Leeper, DB, Sokolov, BP, Pollard, MD, Bagasra, O & Prockop, DJ Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA, (1995). 92, 4857–4861.
Horwitz, EM, Prockop, DJ, Fitzpatrick, LA, Koo, WW, Gordon, PL, Neel, M, Sussman, M, Orchard, P, Marx, JC, Pyeritz, RE & Brenner, MK Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med, (1999). 5, 309–313.
Horwitz, EM, Prockop, DJ, Gordon, PL, Koo, WW, Fitzpatrick, LA, Neel, MD, McCarville, ME, Orchard, PJ, Pyeritz, RE & Brenner, MK Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, (2001). 97, 1227–1231.
Azizi, SA, Stokes, D, Augelli, BJ, DiGirolamo, C & Prockop, DJ Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc Natl Acad Sci USA, (1998). 95, 3908–3913.
Orlic, D, Kajstura, J, Chimenti, S, Jakoniuk, I, Anderson, SM, Li, B, Pickel, J, McKay, R, Nadal-Ginard, B, Bodine, DM, Leri, A & Anversa, P Bone marrow cells regenerate infarcted myocardium. Nature, (2001). 410, 701–705.
Almeida-Porada, G, Flake, AW, Glimp, HA & Zanjani, ED Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol, (1999). 27, 1569–1575.
Fibbe, WE, Noort, WA, Schipper, F & Willemze, R Ex vivo expansion and engraftment potential of cord blood-derived CD34+ cells in NOD/SCID mice. Ann NY Acad Sci, (2001). 938, 9–17.
Agematsu, K & Nakahori, Y Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans. Br J Haematol, (1991). 79, 359–365.
Laver, J, Jhanwar, SC, O’Reilly, RJ & Castro-Malaspina, H Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. Blood, (1987). 70, 1966–1968.
Koc, ON, Peters, C, Aubourg, P, Raghavan, S, Dyhouse, S, DeGasperi, R, Kolodny, EH, Yoseph, YB, Gerson, SL, Lazarus, HM, Caplan, AI, Watkins, PA & Krivit, W Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol, (1999). 27, 1675–1681.
Simmons, PJ, Przepiorka, D, Thomas, ED & Torok-Storb, B Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature, (1987). 328, 429–432.
Cilloni, D, Carlo-Stella, C, Falzetti, F, Sammarelli, G, Regazzi, E, Colla, S, Rizzoli, V, Aversa, F, Martelli, MF & Tabilio, A Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood, (2000). 96, 3637–3643.
Tanaka, J, Kasai, M, Imamura, M, Masauzi, N, Ohizumi, H, Matsuura, A, Morii, K, Kiyama, Y, Naohara, T, Saitoh, M, Higa, T, Sakurada, K & Miyazaki, T Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation. Br J Haematol, (1994). 86, 436–438.
Piersma, AH, Ploemacher, RE & Brockbank, KG Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors. Exp Hematol, (1983). 11, 884–890.
Keating, A, Singer, JW, Killen, PD, Striker, GE, Salo, AC, Sanders, J, Thomas, ED, Thorning, D & Fialkow, PJ Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature, (1982). 298, 280–283.
Golde, DW, Hocking, WG, Quan, SG, Sparkes, RS & Gale, RP Origin of human bone marrow fibroblasts. Br J Haematol, (1980). 44, 183–187.
Friedenstein, AJ, Ivanov-Smolenski, AA, Chajlakjan, RK, Gorskaya, UF, Kuralesova, AI, Latzinik, NW & Gerasimow, UW Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. Exp Hematol, (1978). 6, 440–444.
Wilson, FD, Konrad, PN, Greenberg, BR, Klein, AK & Walling, PA Cytogenetic studies on bone marrow fibroblasts from a male-female hematopoietic chimera. Evidence that stromal elements in human transplantation recipients are of host type. Transplantation, (1978). 25, 87–88.
Hou, Z, Nguyen, Q, Frenkel, B, Nilsson, SK, Milne, M, van Wijnen, AJ, Stein, JL, Quesenberry, P, Lian, JB & Stein, GS Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci USA, (1999). 96, 7294–7299.
Pereira, RF, O’Hara, MD, Laptev, AV, Halford, KW, Pollard, MD, Class, R, Simon, D, Livezey, K & Prockop, DJ Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA, (1998). 95, 1142–1147.
Brouard, N, Chapel, A, Thierry, D, Charbord, P & Peault, B Transplantation of gene-modified human bone marrow stromal cells into mouse-human bone chimeras. J Hematother Stem Cell Res, (2000). 9, 175–181.
Bierhuizen, MF, Westerman, Y, Visser, TP, Wognum, AW & Wagemaker, G Green fluorescent protein variants as markers of retroviral-mediated gene transfer in primary hematopoietic cells and cell lines. Biochem Biophys Res Commun, (1997). 234, 371–375.
Moritz, T, Dutt, P, Xiao, X, Carstanjen, D, Vik, T, Hanenberg, H & Williams, DA Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood, (1996). 88, 855–862.
Brockbank, KG, Ploemacher, RE & van Peer, CM An in vitro analysis of murine hemopoietic fibroblastoid progenitors and fibroblastoid cell function during aging. Mech Ageing Dev, (1983). 22, 11–21.
Phinney, DG, Kopen, G, Isaacson, RL & Prockop, DJ Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem, (1999). 72, 570–585.
Quarto, R, Mastrogiacomo, M, Cancedda, R, Kutepov, SM, Mukhachev, V, Lavroukov, A, Kon, E & Marcacci, M Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med, (2001). 344, 385–386.
Nikkels, PG, de Jong, JP & Ploemacher, RE Radiation sensitivity of hemopoietic stroma: long-term partial recovery of hemopoietic stromal damage in mice treated during growth. Radiat Res, (1987). 109, 330–341.
Barry, FP, Boynton, RE, Haynesworth, S, Murphy, JM & Zaia, J The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun, (1999). 265, 134–139.
Haynesworth, SE, Baber, MA & Caplan, AI Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone, (1992). 13, 69–80.
Lahiri, SK, Keizer, HJ & van Putten, LM The efficiency of the assay for heamopoietic colony forming cells. Cell Tissue Kinet, (1970). 3, 355–362.
Vos, O, Luiten, F & Ploemache, RE Lodging of CFU-S under various circumstances in bone marrow, spleen and liver. Exp Hematol, (1980). 8, 960–966.
Piersma, AH, Ploemacher, RE & Brockbank, KG Transplantation of bone marrow fibroblastoid stromal cells in mice via the intravenous route. Br J Haematol, (1983). 54, 285–290.
Piersma, AH, Brockbank, KG, Ploemacher, RE & Ottenheim, CP Recovery of hemopoietic stromal progenitor cells after lethal total-body irradiation and bone marrow transplantation in mice. Transplantation, (1985). 40, 198–201.
Piersma, AH, Brockbank, KG, Ploemacher, RE, van Vliet, E, Brakel-van Peer, KM & Visser, PJ Characterization of fibroblastic stromal cells from murine bone marrow. Exp Hematol, (1985). 13, 237–243.
Devine, SM & Hoffman, R Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol, (2000). 7, 358–363.
Hurwitz, DR, Kirchgesser, M, Merrill, W, Galanopoulos, T, McGrath, CA, Emami, S, Hansen, M, Cherington, V, Appel, JM, Bizinkauskas, CB, Brackmann, HH, Levine, PH & Greenberger, JS Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther, (1997). 8, 137–156.
Gao, J, Dennis, JE, Muzic, RF, Lundberg, M & Caplan, AI The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs, (2001). 169, 12–20.
van der Loo, JC & Ploemacher, RE Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood, (1995). 85, 2598–2606.
Szilvassy, SJ, Bass, MJ, Van Zant, G & Grimes, B Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood, (1999). 93, 1557–1566.
Glimm, H, Oh, IH & Eaves, CJ Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood, (2000). 96, 4185–4193.
Berrios, VM, Dooner, GJ, Nowakowski, G, Frimberger, A, Valinski, H, Quesenberry, PJ & Becker, PS The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Exp Hematol, (2001). 29, 1326–1335.
Ramirez, M, Segovia, JC, Benet, I, Arbona, C, Guenechea, G, Blaya, C, Garcia-Conde, J, Bueren, JA & Prosper, F Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins. Br J Haematol, (2001). 115, 213–221.
Conget, PA & Minguell, JJ Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol, (1999). 181, 67–73.
Wagers, AJ, Allsopp, RC & Weissman, IL Changes in integrin expression are associated with altered homing properties of Lin([minus sign]/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol, (2002). 30, 176–185.
Nilsson, SK, Dooner, MS & Quesenberry, PJ Synchronized cell-cycle induction of engrafting long-term repopulating stem cells. Blood, (1997). 90, 4646–4650.
Jetmore, A, Plett, PA, Tong, X, Wolber, FM, Breese, R, Abonour, R, Orschell-Traycoff, CM & Srour, EF Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood, (2002). 99, 1585–1593.
Gothot, A, van der Loo, JC, Clapp, DW & Srour, EF Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood, (1998). 92, 2641–2649.
Colter, DC, Class, R, DiGirolamo, CM & Prockop, DJ Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, (2000). 97, 3213–3218.
Kuznetsov, S & Gehron Robey, P Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int, (1996). 59, 265–270.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rombouts, W., Ploemacher, R. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17, 160–170 (2003). https://doi.org/10.1038/sj.leu.2402763
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402763
Keywords
This article is cited by
-
Safety and outcomes analysis: transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy
Stem Cell Research & Therapy (2023)
-
Nongenetic surface engineering of mesenchymal stromal cells with polyvalent antibodies to enhance targeting efficiency
Nature Communications (2023)
-
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Acta Pharmacologica Sinica (2023)
-
CXCR4 enhances the inhibitory effects of bone mesenchymal stem cells on lung cell apoptosis in a rat model of smoking-induced COPD
Apoptosis (2023)
-
Hypoxia and interleukin-1-primed mesenchymal stem/stromal cells as novel therapy for stroke
Human Cell (2023)